v3.26.1
Note 15 - Stockholders' Equity (Details Textual)
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 30, 2026
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Feb. 28, 2025
USD ($)
$ / shares
shares
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2025
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Feb. 12, 2026
USD ($)
$ / shares
shares
Nov. 24, 2025
$ / shares
Oct. 31, 2025
$ / shares
Jul. 31, 2025
USD ($)
$ / shares
Mar. 07, 2025
$ / shares
shares
Feb. 20, 2025
shares
Jun. 30, 2015
shares
Common Stock, Shares, Issued (in shares)       9,428,707   8,772,872              
Common Stock, Shares, Outstanding (in shares)       9,428,707                  
Preferred Stock, Shares Authorized (in shares)       25,000,000             25,000,000 25,000,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       0                  
Long-Term Debt, Gross | $       $ 15,712,000   $ 15,746,000              
July Note [Member]                          
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares       $ 0.75                  
Long-Term Debt, Gross | $       $ 500,744                  
Debt Instrument, Convertible, Number of Equity Instruments       667,659                  
Senior Secured Convertible Note [Member] | The 3i, LP [Member]                          
Long-Term Debt, Gross | $       $ 3,625,896   $ 3,859,541              
Debt Instrument, Convertible, Number of Equity Instruments       4,082,407   4,393,933              
Amortization of Debt Discount (Premium) | $       $ 37,812                  
Senior Secured Convertible Note [Member] | The 3i, LP [Member] | Half Million Portion of Note [Member]                          
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares       $ 0.57                  
Debt Instrument, Face Amount | $       $ 500,000                  
Senior Secured Convertible Note [Member] | The 3i, LP [Member] | July Note [Member]                          
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares               $ 0.75 $ 1 $ 1.72      
Long-Term Debt, Gross | $           $ 500,744              
Debt Instrument, Face Amount | $                   $ 3,272,966      
Debt Instrument, Payment Deferred | $             $ 606,054            
Senior Secured Convertible Note [Member] | The 3i, LP [Member] | Minimum [Member]                          
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares       $ 0.75   $ 0.75   0.75          
Senior Secured Convertible Note [Member] | The 3i, LP [Member] | Maximum [Member]                          
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares       $ 1.1   $ 1.1   $ 1.1          
Underwriters Warrants [Member]                          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)                     62,500    
Class of Warrant or Right, Percentage of Shares Issued in Offering                     5.00%    
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares                     $ 4    
Series Z Preferred Stock [Member]                          
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares | $   $ 1,936,893                      
Conversion From Senior Convertible Note With 3I, LP to Common Stock [Member]                          
Debt Conversion, Original Debt, Amount | $           $ 2,897,196              
Debt Conversion, Converted Instrument, Shares Issued (in shares)           3,166,667              
Conversion From Senior Convertible Note With 3I, LP to Common Stock [Member] | Minimum [Member]                          
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares           $ 0.75              
Conversion From Senior Convertible Note With 3I, LP to Common Stock [Member] | Maximum [Member]                          
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares           $ 1              
The 3i, LP [Member] | Warrant Issued in Consideration of Deferral of Debt Payment [Member]                          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             405,000            
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares             $ 0.01            
Warrants and Rights Outstanding, Term (Year)             5 years            
Warrants and Rights Outstanding | $             $ 202,734            
The 3i, LP [Member] | Warrant Issued in Consideration of Deferral of Debt Payment [Member] | Measurement Input, Share Price [Member]                          
Warrants and Rights Outstanding, Measurement Input             0.5077            
The 3i, LP [Member] | Warrant Issued in Consideration of Deferral of Debt Payment [Member] | Measurement Input, Exercise Price [Member]                          
Warrants and Rights Outstanding, Measurement Input             0.01            
The 3i, LP [Member] | Warrant Issued in Consideration of Deferral of Debt Payment [Member] | Measurement Input, Expected Term [Member]                          
Warrants and Rights Outstanding, Measurement Input             5            
The 3i, LP [Member] | Warrant Issued in Consideration of Deferral of Debt Payment [Member] | Measurement Input, Risk Free Interest Rate [Member]                          
Warrants and Rights Outstanding, Measurement Input             0.0367            
The 3i, LP [Member] | Warrant Issued in Consideration of Deferral of Debt Payment [Member] | Measurement Input, Expected Dividend Rate [Member]                          
Warrants and Rights Outstanding, Measurement Input             0            
The 3i, LP [Member] | Warrant Issued in Consideration of Deferral of Debt Payment [Member] | Measurement Input, Price Volatility [Member]                          
Warrants and Rights Outstanding, Measurement Input             1.005            
The 2015 Plan [Member]                          
Common Stock, Capital Shares Reserved for Future Issuance (in shares)                         1,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)       0   0              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         0                
The 2025 Plan [Member]                          
Common Stock, Capital Shares Reserved for Future Issuance (in shares) 5,000,000                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       0 0                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number (in shares)       0   50              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares       $ 163   $ 163              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period (in shares)       50   450              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)       0 0                
Restricted Stock [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)       1,995,000                  
Restricted Stock [Member] | The 2025 Plan [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 1,995,000                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 0.649                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Grant Date Fair Value | $ $ 1,295,000                        
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | $       $ 1,295,000                  
Restricted Stock [Member] | The 2025 Plan [Member] | Share-Based Payment Arrangement, Tranche One [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 1,116,250                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Month) 36 months                        
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Month)       36 months                  
Restricted Stock [Member] | The 2025 Plan [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                          
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) 878,750                        
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Month)       10 months                  
Including Restricted Stock Awards [Member]                          
Common Stock, Shares, Issued (in shares)       11,423,707                  
Series B Preferred Stock [Member]                          
Preferred Stock, Shares Authorized (in shares)     2,000,000 2,000,000   2,000,000              
Preferred Stock, Shares Issued (in shares)       985,063   985,063              
Preferred Stock, Shares Outstanding (in shares)       985,063                  
Preferred Stock, No Par Value (in dollars per share) | $ / shares     $ 0 $ 0   $ 0              
Common Stock, Closing Price Requirement on the Date of Conversion (in dollars per share) | $ / shares     $ 40                    
Preferred Stock, Percentage of Outstanding Stock Required for Appointments to Board     50.00%                    
Series B Preferred Stock [Member] | Nectarine Management LLC [Member]                          
Stock Issued During Period, Shares, New Issues (in shares)     985,063                    
Proceeds from Issuance of Convertible Preferred Stock | $     $ 30,000                    
Series Z Non-redeemable Preferred Stock [Member]                          
Preferred Stock, Shares Authorized (in shares)       3,500,000                  
Preferred Stock, Shares Issued (in shares)       1,467,532                  
Preferred Stock, Dividend Rate, Percentage       8.00%                  
Preferred Stock, Shares Outstanding (in shares)       1,467,532                  
Series Z Preferred Stock [Member]                          
Preferred Stock, Shares Authorized (in shares)   3,500,000                      
Preferred Stock, Dividend Rate, Percentage   8.00%                      
Preferred Stock, No Par Value (in dollars per share) | $ / shares   $ 0                      
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)   1,467,532                      
Preferred Stock, Dividend Rate, Per-Dollar-Amount (in dollars per share) | $ / shares   $ 1.32                      
Interest Expense, Operating and Nonoperating | $       $ 39,500                  
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount | $       $ 2,015,000   $ 1,976,000              
Series Z Preferred Stock [Member] | Conversion of Long Term Debt to Series Z Preferred Stock [Member]                          
Debt Conversion, Original Debt, Amount | $   $ 1,940,000                      
Series Z Preferred Stock [Member] | BP Peptides, LLC [Member]                          
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)   642,364                      
Series Z Preferred Stock [Member] | Brookstone Partners Acquisition XXI Corporation [Member]                          
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)   825,168